Ferring to acquire ovary-in-a-dish startup Gameto for up to $1.38B
Ferring Pharmaceuticals has signed an agreement to acquire the fertility startup Gameto in a deal that could be worth up to $1.3825 billion, the companies told Endpoints News ahead of a
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.